logo

For the Inventor, By the Inventor

Toyonaka, Japan

Yoshiyasu Furukawa

This inventor holds 14 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiyasu Furukawa. Retrieved from https://idiyas.com/inventor/yoshiyasu-furukawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 280(Granted Patents)


Location History:

  • Toyonaka, JA (1976)
  • Osaka, JA (1977)
  • Osaka, JP (1980)
  • Shinsenriminami, JP (1981)
  • Toyonaka, JP (1978 - 1982)
  • Takarazuka, JP (1985 - 1986)
  • Hyogo, JP (1989)

Company Filing History:

goldMedal14 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1976-1989

Loading Chart...
14 patents (USPTO):Explore Patents
1. 4824848 - Pyrazolo[3,4-d]pyrimidine derivatives, their production and use (1989-04-25),
2. 4603203 - 3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof (1986-07-29),
3. 4582847 - 4-chloro-2-phenylimidazole-5-acetic acid derivatives and use as (1986-04-15),
4. 4504662 - Isoxazolopyrimidine derivatives (1985-03-12),
5. 4355040 - Hypotensive imidazole-5-acetic acid derivatives (1982-10-19),
6. 4340598 - Hypotensive imidazole derivatives (1982-07-20),
7. 4258033 - 2,6-Diaminonebularines (1981-03-24),
8. 4255565 - Production of 2,6-diaminonebularines (1981-03-10),
9. 4225591 - 2,6-Diaminonebularines (1980-09-30),
10. 4207324 - 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their (1980-06-10),
11. 4202975 - Isoxazolo[3,4-d]pyrimidines (1980-05-13),
12. 4129654 - Isoxazolo[3,4-d]pyrimidines useful as antiinflammatory-analgesic agents (1978-12-12),
13. 4052391 - 3-(Disubstituted)aminoisothiazolo[3,4-d]pyrimidines (1977-10-04),
14. 3959280 - 3-(Disubstituted)aminoisothiazolo[3,4-d]pyrimidines (1976-05-25),

Title: The Innovative Contributions of Yoshiyasu Furukawa

Introduction

Yoshiyasu Furukawa is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 14 patents to his name, Furukawa's work has had a substantial impact on medical science.

Latest Patents

Furukawa's latest patents include innovative compounds such as pyrazolo[3,4-d]pyrimidine derivatives, which are characterized by their unique chemical structures. These derivatives are represented by a general formula that allows for various substitutions, making them versatile in their applications. Another notable patent involves 3-aminopyrazolo[3,4-d]pyrimidine derivatives, which are useful for their anti-inflammatory, analgesic, and antipyretic properties. These compounds are designed to provide effective treatment options for various medical conditions.

Career Highlights

Yoshiyasu Furukawa is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company known for its commitment to innovation and research. His work at Takeda has allowed him to focus on developing new therapeutic agents that address unmet medical needs. Furukawa's dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Furukawa has collaborated with esteemed colleagues such as Ryuji M Marumoto and Kohei Nishikawa. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.

Conclusion

Yoshiyasu Furukawa's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic agents, showcasing the vital role of inventors in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…